clinical trial · NCT04588688
Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency
Tobias Else·phase2·terminated·n = 3
Central Adrenal InsufficiencyMifepristoneMifepristone
brief summary
The researchers propose the use of mifepristone as an alternative way to test for Central Adrenal Insufficiency (CAI). They want to assess the feasibility of recruitment and the efficacy of the purposed method.
started
May 5, 2021
primary completion
Aug 1, 2021
completion
Aug 1, 2021
last updated
Jun 12, 2023
detailed description
Recruitment for this trial was legally opened on February 17, 2020. When the record was first released, it incorrectly listed the recruitment status as "Not Yet Recruiting." This mistake was noticed before the first participant actually enrolled, May 5, 2021. The decision to terminate for low recruitment was made on Sept 7, 2022, approximately 30 months later, as at that point it was deemed impossible to reach the initial enrollment target of 26.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol